Stocks and Investing
Stocks and Investing
Fri, June 11, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, June 10, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Josh Silverstein Initiated (CC) at Buy on, Jun 10th, 2021
Josh Silverstein of Wolfe Research, Initiated "The Chemours Company" (CC) at Buy on, Jun 10th, 2021.
Josh has made no other calls on CC in the last 4 months.
There are 4 other peers that have a rating on CC. Out of the 4 peers that are also analyzing CC, 1 agrees with Josh's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Vincent Andrews of "Morgan Stanley" Maintained at Hold with Increased Target to $35 on, Monday, May 10th, 2021
These are the ratings of the 3 analyists that currently disagree with Josh
- Robert Koort of "Goldman Sachs" Upgraded from Hold to Strong Buy and Increased Target to $47 on, Wednesday, June 9th, 2021
- Matthew DeYoe of "B of A Securities" Initiated at Strong Buy and Held Target at $42 on, Thursday, May 20th, 2021
- David Coleman of "Argus Research" Upgraded from Hold to Strong Buy and Held Target at $40 on, Thursday, May 6th, 2021
Contributing Sources